Differentially expressed genes in A2780 resistant and sensitive to cisplatin ovarian cancer originated cell lines. by Hadi Alizadeh (20854757)

Subjects:

Cell cycle analysis of A2780 cells following AGPAT3 overexpression. by Hadi Alizadeh (20854757)

Subjects:

Characterization of cisplatin resistance phenotype in A2780 and A2780cp cells. by Hadi Alizadeh (20854757)

Subjects:

Viability and drug resistance of A2780 cells following AGPAT3 overexpression. by Hadi Alizadeh (20854757)

Subjects:

Presenting the original images of Western blotting analysis. by Hadi Alizadeh (20854757)

Subjects:

Nucleotide sequence alignment of aflatoxin genes <i>Nor, Omt</i>, <i>Ver</i> and <i>aflR</i> treated with <i>U. epigea</i> extract, Ag/ZnO (Biosynthesized and Conventional) nanopar... by Martha Cebile Jobe (21175426)

Decreases in muscle size, muscle force, and TB mass in 3-mo Lmna^HSA-cko mice. by Lei Xiong (334812)

RCT enrollment, intervention, and assessments. by Jaclynn Hawkins (14709729)

Subjects:

Primary and secondary outcome measures. by Jaclynn Hawkins (14709729)

Subjects:

Temporal distributions of inscriptions and occupations using uniform 50-years-long timeblocks. by Vojtěch Kaše (6156971)

<i>Aspergillus flavus</i> mRNA expression (a) <i>aflD</i> and (c) <i>aflR</i> and phylogenetic analysis of (b) <i>aflD</i> and (d) <i>aflR</i> after exposure to 50 mg/mL of <i>U. e... by Martha Cebile Jobe (21175426)

Drugs IC₅₀s data during the study period. by Winnie Okore (14139712)

Summary of cell-based assay EC50 results for WT BMP9 and A347E variant. by Tobias G. Schips (21799838)

Barbie’s ankle equinus measured at 50 degrees as equnius posture (a) and flat foot posture measured at 0 degrees (b), with a handheld goniometer. by Cylie Williams (3446018)

Overlap between provinces with an anomalous decrease in hunting licences and excess mortality, for 2020–2021 and 2021–2022. by Jacopo Cerri (6271958)

S1 Data - by Nobutake Yamamichi (381131)

Subjects:

Characteristics of participants admitted to an intensive care unit by smoking status. by Karl Stattin (11836305)

Subjects:

Sensitivity analysis with follow-up beginning three years after baseline. by Karl Stattin (11836305)

Subjects:

Trend in PPI and H₂RA uses from 2010 to 2019 in Japan. by Nobutake Yamamichi (381131)

Subjects:

Risk of contracting any infection and pneumonia, being admitted to and intensive care unit and dying by smoking status. by Karl Stattin (11836305)

Subjects: